Stockreport

Elicio Therapeutics Announces $6.0 Million Private Placement Financing

Elicio Therapeutics, Inc.  (ELTX) 
PDF BOSTON, March 18, 2024 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio Therapeutics” or “Elicio”), a clinical-stage biotechnology company developi [Read more]